J&J Acquisitions Governed By Payback Potential, Despite Credit “Uncertainty”
Executive Summary
Maintaining a stellar credit rating is not a constraint on how much Johnson & Johnson is willing to spend on acquisitions, Chief Financial Officer Dominic Caruso said during the company's April 15 first quarter earnings call
You may also be interested in...
AstraZeneca Sales Force Restructuring Boosts Operating Profit, Not Sales
AstraZeneca's efforts to restructure its EU sales force have helped the company improve its margins
AstraZeneca Sales Force Restructuring Boosts Operating Profit, Not Sales
AstraZeneca's efforts to restructure its EU sales force have helped the company improve its margins
Bristol Readies Abilify Sales Force For Major Depressive Disorder Push
Bristol-Myers Squibb has restructured its sales force to support the launch of its atypical antipsychotic Abilify as an adjunct treatment for adults with major depressive disorder, Worldwide Pharmaceuticals Chief Operating Officer Lamberto Andreotti said during the company's 2007 fourth-quarter earnings call Jan. 31